# Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy

> **NCT04415944** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 10 (actual)

## Conditions studied

- Ovarian Epithelial Cancer Stage I
- Ovarian Epithelial Cancer Stage II
- Ovarian Epithelial Cancer Stage III
- Stage I Fallopian Tube Cancer
- Stage II Fallopian Tube Cancer
- Stage III Fallopian Tube Cancer
- Peritoneal Carcinoma

## Interventions

- **PROCEDURE:** Second look laparoscopy reassessment surgery (SLLRS)
- **DRUG:** HIPEC with Carboplatin
- **OTHER:** FACT-O Quality of Life Questionnaire

## Key facts

- **NCT ID:** NCT04415944
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-20
- **Primary completion:** 2025-09-19
- **Final completion:** 2026-01-23
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04415944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04415944, "Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04415944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*